Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Adenovirus associated viral vector serotype 2 containing the human RPE65 gene

EU orphan designation number: EU/3/12/981   
Active ingredient: Adenovirus associated viral vector serotype 2 containing the human RPE65 gene
Indication: Treatment of Leber’s congenital amaurosis
Sponsor: Alan Boyd Consultants Ltd
Electra House, Crewe Business Park, Crewe, Cheshire CW1 6GL, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
04/04/2012 Centralised Orphan - Designation EMA/OD/150/11 (2012)2351 of 02/04/2012